Immuneering Corporation (IMRX) vs Invivyd, Inc. (IVVD)
Immuneering Corporation and Invivyd, Inc. are both Biotechnology companies. Immuneering Corporation and Invivyd, Inc. are of similar size ($280.8M and $274.1M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −84.8%. Immuneering Corporation has the higher net margin (0.00% vs −183.9%) and the higher return on invested capital (−97.1% vs −334.9%). Across the 16 metrics below, Immuneering Corporation leads on 11 and Invivyd, Inc. on 5.
Valuation
Profitability
| Metric | IMRX | IVVD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 92.23% | 65.16% |
| Operating margin | 0.00% | (192.81%) | 0.00% |
| Net margin | 0.00% | (183.90%) | 0.00% |
| Free cash flow margin | 0.00% | (187.88%) | 0.00% |
| Return on equity | (52.15%) | (95.89%) | (57.72%) |
| Return on assets | (47.31%) | (69.69%) | (49.22%) |
| Return on invested capital | (97.14%) | (334.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack